Increases holding to 54% in Global Gaming - declares intention to make mandatory public offer

2020-08-26

Download PDF
Enlabs AB (“Enlabs”) has today acquired 9,878,086 shares in Global Gaming 555 AB (“Global Gaming”) for SEK 11 per share. The shares will be paid with 50% in cash and with 50% by issuance of new shares in Enlabs. The acquisition increases Enlabs holding from 29.89% to 54.06% of all shares and votes in Global Gaming.

The acquisition of the additional shares in Global Gaming means that Enlabs is obliged to within four weeks make a public offer to tender the remaining shares in Global Gaming (a so-called mandatory public offer, Swe: budpliktsbud).

Enlabs intends to, within four weeks, make a public offer to acquire the remaining shares in Global Gaming. In such public offer, Enlabs will offer all shareholders in Global Gaming to transfer their shares to Enlabs against a consideration corresponding to SEK 11 per share in Global Gaming, which is approximately 34% above the average trading price for Global Gaming shares during the last ninety days of trading. The consideration will not be increased by Enlabs.

For more information, please contact:

Enlabs AB
George Ustinov, CEO and Group president
[email protected] / +371 29424175


This disclosure contains information that ENLABS is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, at 26-08-2020 22:10 CET.

About Enlabs

Enlabs stands for Entertainment Laboratories. Enlabs are a company that creates entertainment through innovative thinking within gaming. The corporate group has offices in Tallinn, Riga, Vilnius, Malta, Marbella, Minsk and Stockholm. The operating subsidiaries hold national licenses for their operations and the Group employs approximately 225 employees. Enlabs AB (NLAB) is listed at Nasdaq First North Growth Market with Redeye AB as Certified Adviser: [email protected], +46 (0)8 121 576 90.  

For more information, visit enlabs.com

Subscribe to our press releases & reports